Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abroad, absolute, accuracy, adhere, alopecia, Bay, begun, Bevacizumab, blinded, bloodstream, Box, buparlisib, Catherine, Cayman, Celgene, Celldex, cGCP, Chancery, clearance, confidence, convenience, count, criminal, CRO, CT, damage, daunorubicin, DaunoXome, DCVax, defraud, demand, denial, dermatological, detention, deviating, dividing, doctrine, dropping, DSMB, Duarte, duty, Edition, enact, enacted, ethical, false, febrile, fewer, fiduciary, floor, Florida, forma, forum, Francisco, fraud, fraudulent, Galen, gap, Grand, hair, hazard, heavily, hinder, HIV, honorary, hydrazine, implanted, imprisonment, inapplicable, incidence, incidental, indirectly, induce, infection, infused, inhaled, insert, instilled, interval, invasive, jeopardize, Jewish, judicial, Jupiter, Kaposi, knowingly, lab, landlord, legislation, legislative, lengthy, lieu, LSU, Meadowbrook, minimal, month, narrow, necrotizing, negative, Northwest, notwithstanding, Obama, outlining, outpatient, outweigh, owed, package, packaging, Park, Patterson, Pennsylvania, Permeability, PFS, platform, play, pomalidamide, Portability, prescription, privacy, pro, promulgated, proper, proximity, radiology, reacquired, rebate, Reconciliation, recordkeeping, recoverable, referral, Regalty, regression, regular, reliance, Relief, relieve, remuneration, renal, repeat, replaced, replenishment, restructuring, revaluation, reveal, revocation, rindopepimut, Road, rolling, saline, Salkind, scale, scheme, Secondary, selumetinib, shutdown, Spoonbill, statute, strict, STS, sued, suffice, sunshine, Switching, Taxpayer, temozolomide, Tracon, trail, trillion, unanticipated, undesirable, uniformity, unreliable, upper, violate, violation, volume, vomiting, warning, Wayne, West, wife, willfully, Winward, Wrack, writing
Removed:
abnormal, accelerating, accept, account, accounted, added, adenocarcinoma, adult, advent, affinity, alkaloid, alter, Anderson, antidilution, antimetabolite, approximated, Arrieta, arsenic, Arzerra, ArzerraTM, ATO, ATRA, attached, BC, bearing, bind, binding, blast, Campath, Canadian, capable, carboplatin, carcinoma, cavity, cellular, CFAR, chemical, chest, CHOP, chromosome, cisplatin, CLL, CML, combined, commercialized, comprising, conferred, continual, contracted, CP, CRABP, Craig, crystal, cyclophosphamide, database, deconsolidated, deduction, defending, depositor, dermal, Designation, diagnosed, doublet, DOXO, Eisai, Eli, enforcing, epithelium, eribulin, Essentially, fast, fludarabine, fluid, formulation, functioning, fusion, gene, heartbeat, hydrazone, hyperCFAD, idarubicin, IIIB, improved, induction, inhibitory, institution, intolerant, intravenously, investigator, Iressa, irregular, Journal, lessen, licensor, Lilly, manner, Mello, metabolic, Mexico, mutation, myeloid, necitumumab, neurological, North, NSCLC, OFAR, Oforta, OfortaTM, Orphan, OSI, overexpressed, palifosfamide, partially, Pfizer, Ph, Philadelphia, placement, platinum, pleural, PML, prosecuting, published, randomized, RARa, receptor, recording, relapse, remission, representation, reproducible, resulted, retreated, revert, Rituxan, RNAi, Secondarily, separate, skin, Sprycel, Squibb, Sr, step, stringent, tablet, Tarceva, targeting, Tasigna, taxane, tolerated, translocation, trioxide, vinka, vitro, Western, ZIOPHARM
Filing tables
Filing exhibits
Related press release
LADX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CytRx Corporation
Los Angeles, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S3 (Nos. 333-100947, 333-109708, 333-106629, 333-109708, 333-133269, 333-142591, 333-147605, 333-170437, 333-185308, 333-192597, 333-193064 and 333-193673) and Form S8 (Nos. 333-84657, 333-68200, 333-91068, 333-93305, 333-123339 and 333-163212) of CytRx Corporation of our reports dated March 4, 2014, relating to the consolidated financial statements and schedule, and the effectiveness of CytRx Corporation’s internal control over financial reporting, which appears in this Form 10-K.
/s/ BDO USA, LLP
Los Angeles, California
March 4, 2014